The trading price of Citius Pharmaceuticals Inc (NASDAQ:CTXR) closed lower on Monday, April 22, closing at $0.73, -2.68% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $1.62 and a 52-week low of $0.60. Over the past month, the stock has lost -2.15% in value.
Citius Pharmaceuticals Inc, whose market valuation is $116.80 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.05 per share this quarter, however they have predicted annual earnings per share of -$0.21 for 2024 and $0.12 for 2025. It means analysts are expecting annual earnings per share growth of 4.50% this year and 157.10% next year.
Analysts have forecast the company to bring in revenue of $14.81 million for the current quarter, with the likely lows of -$ and highs of $44.44 million. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $61.72 million.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Citius Pharmaceuticals Inc no upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest CTXR has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a Hold, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that CTXR’s price is currently -14.85% off the SMA20 and -7.00% off the SMA50. The RSI metric on the 14-day chart is currently showing 41.14, and weekly volatility stands at 14.90%. When measured over the past 30 days, the indicator reaches 11.66%. Citius Pharmaceuticals Inc (NASDAQ:CTXR)’s beta value is currently sitting at 1.54, while the Average True Range indicator is currently displaying 0.09.
To see how Citius Pharmaceuticals Inc stock has been performing in comparison to its peers in the industry, here are the numbers: CTXR stock’s performance was -2.68% in the latest trading, and -46.80% in the past year.
An evaluation of the daily trading volume of Citius Pharmaceuticals Inc (NASDAQ:CTXR) indicates that the 3-month average is 846.17K.
Currently, records show that 158.86 million of the company’s shares remain outstanding. The insiders hold 7.74% of outstanding shares, whereas institutions hold 16.95%. However, since the stock’s price has seen -2.95% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
